Angiotensin 1-7: A Second Window of Protection in Hypertensive Patients
Angiotensin 1-7: A Second Window of Protection in Hypertensive Patients
dc.contributor.author | Mazin Salaheldin Abdalla Mohamed | |
dc.contributor.author | Muntaser Ibrahim | |
dc.contributor.author | Muhanad S. Abdelwhab | |
dc.date.accessioned | 2022-12-27T06:56:46Z | |
dc.date.available | 2022-12-27T06:56:46Z | |
dc.date.issued | 2019-04-18 | |
dc.description.abstract | The effects of the renin-angiotensin-aldosterone system on the human body are so diverse and our knowledge about them is ever growing. Angiotensin 1-7 has been proven to play protective roles in patients with cardiovascular disorders including but not limited to hypertension. As is the case with Africa, the prevalence of hypertension in Sudan is rising, and its complications could be delayed by pharmacologically manipulating the levels of renin-angiotensin system metabolites. The aim of this review is to compare the advantageous and deleterious effects of Angiotensin 2 in contrast to those of Angiotensin 1-7 and to assert the well-established protective effects of Angiotensin 1-7 (systemically and locally) in hypertensive patients | |
dc.identifier.citation | Mohamed, M. S. A., Ibrahim, M., & Abdelwhab, M. S. (2019). Angiotensin 1-7: A Second Window of Protection in Hypertensive Patients. Cardiology and Angiology: An International Journal, 8(2), 1–7. https://doi.org/10.9734/ca/2019/v8i230095 | |
dc.identifier.issn | 2347520X | |
dc.identifier.uri | http://dspace.napata.edu.sd/handle/123456789/162 | |
dc.language.iso | en | |
dc.title | Angiotensin 1-7: A Second Window of Protection in Hypertensive Patients | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Angiotensin 1-7 A Second Window of Protection in Hypertensive Patients.pdf
- Size:
- 1.41 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: